Company Search:
Advanced Search
Sponsored Links
C4 Therapeutics Inc Company Snapshot
C4 Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares C4 Therapeutics Inc with three other companies in this sector in UNITED STATES : Cidara Therapeutics Inc (2019 sales of $20.92 million of which 100% was Care therapies), Clinuvel Pharmaceuticals Limited ($22.59 million of which 100% was Biotechnology), and Precision BioSciences Inc ($22.24 million of which 93% was Therapeutics).

Sales Analysis.
  Stock Performance Chart for C4 Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/20/2020): 28.50
(Figures in U.S. Dollars)
1 Week 10.3%   13 Weeks 9.2%  
4 Weeks n/a   52 Weeks n/a  
C4 Therapeutics Inc Key Data:
  Ticker: CCCC Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 21,381,000
(Year Ending Jan 2020).
Employees: 88
  Currency: U.S. Dollars Market Cap: 1,226,340,750
  Fiscal Yr Ends: December Shares Outstanding: 43,029,500
  Share Type: COMMON Closely Held Shares: 5,700,540
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.